JESSE KOGELMAN: Open Payments
NPI 1144503491 · TRAVERSE CITY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$9,006 in 64 payments from 14 companies in 2025. Trend: 2023 $2,465 · 2024 $8,006 · 2025 $9,006
Consulting: $6,000Food & beverage: $1,503Travel & lodging: $1,265Education: $238
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 13 | $7,818 |
| Janssen Biotech, Inc. | 11 | $257 |
| ABBVIE INC. | 14 | $219 |
| Regeneron Healthcare Solutions, Inc. | 3 | $139 |
| GENZYME CORPORATION | 5 | $139 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $133 |
| E.R. Squibb & Sons, L.L.C. | 4 | $81 |
| PFIZER INC. | 4 | $78 |
| Galderma Laboratories, L.P. | 2 | $41 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $30 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, Rhapsido, Sotyktu, RINVOQ, ILUMYA, CIBINQO.
Industry payments across MI — which companies pay providers there.
